Butterfly’s core product, the Butterfly iQ, is a $2,000 handheld ultrasound device that uses a semiconductor ultrasound-on-a-chip (CMUT) architecture to deliver whole-body imaging. The iQ pairs with a smartphone app that uses AI and computer-vision "Tele-Guidance" to direct probe placement and uploads encrypted scans to a SOC II–certified, AES 256-bit cloud service that the article describes as HIPPA-compliant. The device was cleared by the FDA in October 2017 for abdominal, cardiovascular, fetal, gynecological, urological, musculoskeletal and other clinical applications. Butterfly says its chip contains up to 10,000 transducer channels and can perform roughly half a trillion operations per second, enabling three-dimensional imaging. The company has begun shipping first units to tens of thousands of customers who reserved them and plans to sell more than a quarter-million devices in the next 18 months. Butterfly is also developing two new products: an ultrasound monitoring patch and an ingestible pill that images internally. Butterfly Network is a Guilford, CT- and NYC-based healthcare startup. It was founded by Jonathan Rothberg and a group of physicists and engineers from MIT and Lincoln Laboratories' through-wall radar team, including Max Tegmark, Nevada Sanchez, Greg Charvat and Tyler Ralston. The company aims to transform medical imaging and non-invasive surgery by leveraging advances in semiconductors, deep learning and cloud computing. Butterfly Network is incubated within 4Combinator, a healthcare startup incubator. The company raised over $100m in funding, with backers that included Aeris Capital and Stanford University. As of the article the company was hiring.

Total raised

$350M

Funding rounds

2

Latest round

Series D

Latest activity

Sep 2018